RP11-434D9.1: A Potential Drug Target for Brain Function (G101928858)

Target Name: LINC02997

NCBI ID: G101928858

LINC02997

Other Name(s): RP11-434D9.1 | long intergenic non-protein coding RNA 2997 | Uncharacterized LOC101928858

RP11-434D9.1: A Potential Drug Target for Brain Function

LINC02997 (RP11-434D9.1) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys. It is a member of the LINC (long non-coding RNA) family, which are characterized by the presence of a conserved RNA structure that can interact with a variety of factors, including proteins and small molecules.

RP11-434D9.1 is a spliced isoform of the LINC02997 gene, which is expressed in the brain and other tissues of the body. It is characterized by a unique structure that includes a 5'-end intron, a 3'-end exon, and a middle exon that is predominantly composed of non-coding RNA.

The LINC02997 protein is of interest as a potential drug target due to its involvement in various cellular processes that are important for brain function. One of its well-documented functions is its role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

RP11-434D9.1 has been shown to play a critical role in the regulation of synaptic plasticity in the brain. It is involved in the production of a variety of proteins that are involved in synaptic plasticity, including the neurotransmitter acetylcholine, which is known for its role in memory and learning.

In addition to its role in synaptic plasticity, RP11-434D9.1 is also involved in the regulation of other cellular processes that are important for brain function. For example, it has been shown to play a role in the regulation of cell survival, as well as the regulation of cell proliferation.

RP11-434D9.1 is also of interest as a potential biomarker for various diseases, including neurodegenerative disorders. Its involvement in the regulation of synaptic plasticity makes it a potentially useful target for drugs that are designed to promote or alleviate synaptic plasticity.

RP11-434D9.1 is also of interest as a potential therapeutic target for a variety of diseases. Its involvement in the regulation of synaptic plasticity makes it a potentially useful target for drugs that are designed to promote or alleviate synaptic plasticity, including neurodegenerative disorders.

In conclusion, RP11-434D9.1 is a protein that is of interest as a potential drug target due to its involvement in various cellular processes that are important for brain function. Its unique structure and its role in the regulation of synaptic plasticity make it a potentially useful target for drugs that are designed to promote or alleviate synaptic plasticity. Further research is needed to fully understand the role of RP11-434D9.1 in the regulation of brain function and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 2997

The "LINC02997 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02997 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets